This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: The Innovations of Timothy S Daynard
Introduction
Timothy S Daynard is an accomplished inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic compounds. His work focuses on innovative solutions for treating hyperproliferative disorders.
Latest Patents
Timothy S Daynard holds a patent for "Hydrazonopyrazole Derivatives And Their Use As Therapeutics." This invention provides pharmaceutical compositions and compounds that demonstrate anti-proliferative activity. The compounds may promote apoptosis in cells that lack normal regulation of the cell cycle and death. The pharmaceutical compositions are particularly useful in treating disorders such as tumor growth, lymphoproliferative diseases, and angiogenesis.
Career Highlights
Timothy is currently associated with Valocor Therapeutics, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating new therapeutic options for patients suffering from various diseases.
Collaborations
He collaborates with notable colleagues, including Zaihui Zhang and Mikhail A Chafeev, who contribute to the innovative research environment at Valocor Therapeutics, Inc.
Conclusion
Timothy S Daynard's contributions to pharmaceutical innovations highlight his commitment to improving therapeutic options for patients. His work in developing hydrazonopyrazole derivatives showcases the potential for new treatments in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile